Regulatory News In Brief
This article was originally published in The Tan Sheet
Executive Summary
Caffeine claims for avitae cross the line; Essiac Tea in hot water with FDA; studies are claims for Nature’s Pearl supplement; “Statin Support” label makes CoQ10 a drug; more Regulatory News In Brief.
You may also be interested in...
Regulatory News In Brief
FDA fires warning shot on Breathable Foods’ “inhalable caffeine”; agency guidance advises against phthalate excipients in drugs; pandemic adverse event reporting guidance finalized; Globe All Wellness recall of tainted supplements is insufficient; more Regulatory News In Brief.
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.